341 related articles for article (PubMed ID: 31293046)
1. Anxiety and depression mediate the association between chemotherapy-induced peripheral neuropathy and fatigue: Results from the population-based PROFILES registry.
Bonhof CS; van de Poll-Franse LV; Vissers PAJ; Wasowicz DK; Wegdam JA; Révész D; Vreugdenhil G; Mols F
Psychooncology; 2019 Sep; 28(9):1926-1933. PubMed ID: 31293046
[TBL] [Abstract][Full Text] [Related]
2. Painful and non-painful chemotherapy-induced peripheral neuropathy and quality of life in colorectal cancer survivors: results from the population-based PROFILES registry.
Bonhof CS; Trompetter HR; Vreugdenhil G; van de Poll-Franse LV; Mols F
Support Care Cancer; 2020 Dec; 28(12):5933-5941. PubMed ID: 32281032
[TBL] [Abstract][Full Text] [Related]
3. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced peripheral neuropathy, physical activity and health-related quality of life among colorectal cancer survivors from the PROFILES registry.
Mols F; Beijers AJ; Vreugdenhil G; Verhulst A; Schep G; Husson O
J Cancer Surviv; 2015 Sep; 9(3):512-22. PubMed ID: 25876556
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.
Mols F; Beijers T; Lemmens V; van den Hurk CJ; Vreugdenhil G; van de Poll-Franse LV
J Clin Oncol; 2013 Jul; 31(21):2699-707. PubMed ID: 23775951
[TBL] [Abstract][Full Text] [Related]
6. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.
Bao T; Basal C; Seluzicki C; Li SQ; Seidman AD; Mao JJ
Breast Cancer Res Treat; 2016 Sep; 159(2):327-33. PubMed ID: 27510185
[TBL] [Abstract][Full Text] [Related]
7. Is CT-based body composition associated with long-term chemotherapy-induced peripheral neuropathy in colorectal cancer survivors?
Smit D; Mols F; Bonhof CS; Bours MJL; Vreugdenhil G; Beijer S
Support Care Cancer; 2022 Jul; 30(7):6071-6078. PubMed ID: 35416503
[TBL] [Abstract][Full Text] [Related]
8. Health-Related Quality of Life in Cancer Survivors with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Clinical Trial.
Bao T; Baser R; Chen C; Weitzman M; Zhang YL; Seluzicki C; Li QS; Piulson L; Zhi WI
Oncologist; 2021 Nov; 26(11):e2070-e2078. PubMed ID: 34390283
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy-induced peripheral neuropathy onset is associated with early risk of depression and anxiety in breast cancer survivors.
McNeish BL; Richardson JK; Whitney DG
Eur J Cancer Care (Engl); 2022 Nov; 31(6):e13648. PubMed ID: 35830192
[TBL] [Abstract][Full Text] [Related]
10. Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population.
Mols F; van de Poll-Franse LV; Vreugdenhil G; Beijers AJ; Kieffer JM; Aaronson NK; Husson O
Eur J Cancer; 2016 Dec; 69():28-38. PubMed ID: 27814471
[TBL] [Abstract][Full Text] [Related]
11. Yoga for cancer survivors with chemotherapy-induced peripheral neuropathy: Health-related quality of life outcomes.
Zhi WI; Baser RE; Zhi LM; Talukder D; Li QS; Paul T; Patterson C; Piulson L; Seluzicki C; Galantino ML; Bao T
Cancer Med; 2021 Aug; 10(16):5456-5465. PubMed ID: 34213086
[TBL] [Abstract][Full Text] [Related]
12. Effects of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Structural Equation Approach With the Theory of Unpleasant Symptoms.
Kim M; Jung MS
Cancer Nurs; 2021 Mar-Apr 01; 44(2):145-153. PubMed ID: 31833921
[TBL] [Abstract][Full Text] [Related]
13. Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: Prevalence, predictors, and impact on quality of life.
Mols F; Schoormans D; de Hingh I; Oerlemans S; Husson O
Cancer; 2018 Jun; 124(12):2621-2628. PubMed ID: 29624635
[TBL] [Abstract][Full Text] [Related]
14. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
Wong ML; Cooper BA; Paul SM; Abrams G; Topp K; Kober KM; Chesney MA; Mazor M; Schumacher MA; Conley YP; Levine JD; Miaskowski C
Support Care Cancer; 2019 Oct; 27(10):3905-3912. PubMed ID: 30770977
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal Associations of Sedentary Behavior and Physical Activity with Quality of Life in Colorectal Cancer Survivors.
Kenkhuis MF; VAN Roekel EH; Breedveld-Peters JJL; Breukink SO; Janssen-Heijnen MLG; Keulen ETP; VAN Duijnhoven FJB; Mols F; Weijenberg MP; Bours MJL
Med Sci Sports Exerc; 2021 Nov; 53(11):2298-2308. PubMed ID: 34033619
[TBL] [Abstract][Full Text] [Related]
16. Dietary Intake of Magnesium or Calcium and Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Patients.
Wesselink E; Winkels RM; van Baar H; Geijsen AJMR; van Zutphen M; van Halteren HK; Hansson BME; Radema SA; de Wilt JHW; Kampman E; Kok DEG
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29570617
[TBL] [Abstract][Full Text] [Related]
17. The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: A cross-sectional study.
McNeish BL; Dittus K; Mossburg J; Krant N; Steinharter JA; Feb K; Cote H; Hehir MK; Reynolds R; Redfern MS; Rosano C; Richardson JK; Kolb N
J Geriatr Oncol; 2024 May; 15(4):101765. PubMed ID: 38581957
[TBL] [Abstract][Full Text] [Related]
18. The course of peripheral neuropathy and its association with health-related quality of life among colorectal cancer patients.
Bonhof CS; van de Poll-Franse LV; Wasowicz DK; Beerepoot LV; Vreugdenhil G; Mols F
J Cancer Surviv; 2021 Apr; 15(2):190-200. PubMed ID: 33185839
[TBL] [Abstract][Full Text] [Related]
19. The magnitude of neurotoxicity in patients with multiple myeloma and the impact of dose modifications: results from the population-based PROFILES registry.
Beijers AJ; Oerlemans S; Mols F; Eurelings M; Minnema MC; Vreugdenhil A; van de Poll-Franse LV
Ann Hematol; 2017 Apr; 96(4):653-663. PubMed ID: 28116479
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced peripheral neuropathy in the detroit research on cancer survivors (ROCS) cohort.
Sreeram K; Seaton R; Greenwald MK; Kamgar M; Assad H; Baird T; Schwartz AG; Ruterbusch J; Simon MS
Cancer Causes Control; 2023 May; 34(5):459-468. PubMed ID: 36934365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
